TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin: TOP2A as marker of response to PLD in ovarian cancer
Erriquez, J, Becco, P, Olivero, M, Ponzone, R, Maggiorotto, F, Ferrero, A, Scalzo, M S, Canuto, E M, Sapino, A, Verdun di Cantogno, L, Bruna, P, Aglietta, M, Di Renzo, M F, Valabrega, G
Published in Gynecologic oncology (01.09.2015)
Published in Gynecologic oncology (01.09.2015)
Get full text
Journal Article
Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization
Annaratone, Laura, Simonetti, Michele, Wernersson, Erik, Marchiò, Caterina, Garnerone, Silvano, Scalzo, Maria Stella, Bienko, Magda, Chiarle, Roberto, Sapino, Anna, Crosetto, Nicola
Published in Oncotarget (21.03.2017)
Published in Oncotarget (21.03.2017)
Get full text
Journal Article
Abstract P6-05-04: Stratification of breast carcinomas with double-equivocal HER2 status
Marchio, C, Trisolini, E, Maletta, F, Annaratone, L, Scalzo, MS, Mascali, D, Verdun di Cantogno, L, Medico, E, Sapino, A
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article